27th Feb 2024 A plain language summary: BI 1015550 for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
23rd Feb 2024 A plain language summary looking at the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer
22nd Jan 2024 A plain language summary looking at the long-term benefit of sotorasib in patients with KRAS G12C–mutated non–small-cell lung cancer
14th Nov 2023 A plain language summary of the ARROW study: pralsetinib in patients with RET fusion–positive non-small cell lung cancer
29th Sep 2023 A plain language summary of the PATHWAY and NAVIGATOR studies: tezepelumab for the treatment of severe asthma
17th Aug 2023 Plain Language Summary: looking at patients with EGFR exon 20 insertion-mutated non-small-cell lung cancer who received amivantamab in the CHRYSALIS study
20th Jul 2023 A Plain Language Summary on the INCREASE study: inhaled treprostinil (Tyvaso) for the treatment of pulmonary hypertension due to interstitial lung disease
21st Jun 2023 Plain Language Summary: updated results from the CROWN study comparing lorlatinib with crizotinib in people with advanced non-small-cell lung cancer
23rd May 2023 Plain Language Summary: tepotinib, a treatment for a subtype of non-small cell lung cancer called MET exon 14 skipping
23rd May 2023 Plain Language Summary: treatment considerations for patients with advanced squamous cell carcinoma of the lung